Literature DB >> 22098348

Iron chelation: deciphering novel molecular targets for cancer therapy. The tip of the iceberg of a web of iron-regulated molecules.

Federica Saletta1, Zaklina Kovacevic, Des Raymond Richardson.   

Abstract

The response of cells to cellular iron depletion is complex with multiple molecules and signaling pathways being involved. Indeed, this is far broader than just the effect on the classical target, ribonucleotide reductase. It is likely that a network of interactions exists between the molecular players and that the relationships currently known only represent the ‘tip of an iceberg’ in terms of understanding the response of cells to iron deprivation. This article describes some of the research being undertaken in this area by the Richardson group at the University of Sydney, Australia [corrected].

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22098348     DOI: 10.4155/fmc.11.154

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  2 in total

1.  Ferrous iron-dependent drug delivery enables controlled and selective release of therapeutic agents in vivo.

Authors:  Edgar Deu; Ingrid T Chen; Erica M W Lauterwasser; Juan Valderramos; Hao Li; Laura E Edgington; Adam R Renslo; Matthew Bogyo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

Review 2.  A Review on Iron Chelators in Treatment of Iron Overload Syndromes.

Authors:  Naser Mobarra; Mehrnoosh Shanaki; Hassan Ehteram; Hajar Nasiri; Mehdi Sahmani; Mohsen Saeidi; Mehdi Goudarzi; Hoda Pourkarim; Mehdi Azad
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.